Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers
Dana-Farber Cancer Institute
240 participants
Oct 31, 2018
INTERVENTIONAL
Conditions
Summary
This research study is evaluating a new method for determining stage and prognosis of individuals with malignant pleural mesothelioma.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
molecular expression tests at the RNA level using approximately 7 or more genes with RTPCR, nanostring or similar platforms
molecular expression tests at the RNA level using approximately 7 or more genes with RTPCR, nanostring or similar platforms
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03683680